Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy.

de Breet, C P D M; Zwaveling, S; Vries, M J A; van Oerle, R G; Henskens, Y M C; Van't Hof, A W J; van der Meijden, P E J; Veenstra, L; Ten Cate, H; Olie, R H

de Breet, C P D M; Zwaveling, S; Vries, M J A; van Oerle, R G; Henskens, Y M C; Van't Hof, A W J; van der Meijden, P E J; Veenstra, L; Ten Cate, H; Olie, R H.

Afiliación

de Breet CPDM; Department of Internal Medicine, Maastricht Universitair Medisch Centrum+, Maastricht, Netherlands.
Zwaveling S; Department of Internal Medicine, Zuyderland Medisch Centrum, Heerlen, Netherlands.
Vries MJA; Department of Biochemistry-CARIM, Maastricht University, Maastricht, Netherlands.
van Oerle RG; Groene Hart Ziekenhuis, Gouda, Netherlands.
Henskens YMC; Department of Internal Medicine, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands.
Van't Hof AWJ; Department of Biochemistry-CARIM, Maastricht University, Maastricht, Netherlands.
van der Meijden PEJ; Department of Biochemistry-CARIM, Maastricht University, Maastricht, Netherlands.
Veenstra L; Department of Cardiology, Zuyderland Medisch Centrum, Heerlen, Netherlands.
Ten Cate H; Department of Cardiology, Maastricht Universitair Medisch Centrum+, Maastricht, Netherlands.
Olie RH; Department of Biochemistry-CARIM, Maastricht University, Maastricht, Netherlands.

Front Cardiovasc Med ; 8: 679934, 2021.

Article en En | MEDLINE | ID: mdl-34179143

Palabras clave

bleeding risk; coagulation factors; dual antiplatelet therapy; percutaneous coronary intervention; thrombin generation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cardiovasc Med Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google